The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Gastrointestinal bleeding is also known as gastrointestinal hemorrhage. It includes all forms of bleeding of gastrointestinal tract, from the mouth to the rectum. Endoscopic hemostatic devices are the primary line of treatment for gastrointestinal bleeding. The major endoscopic hemostatic devices include thermal and mechanical.
The global Gastrointestinal Bleeding Treatment market was valued at US$ 510.6 million in 2023 and is anticipated to reach US$ 628.2 million by 2030, witnessing a CAGR of 2.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Gastrointestinal Bleeding Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal Bleeding Treatment.
Report Scope
The Gastrointestinal Bleeding Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gastrointestinal Bleeding Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastrointestinal Bleeding Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Boston Scientific Corporation
- Olympus Corporation
- CONMED Corporation
- Cook Medical
- Ovesco Endoscopy AG
- Erbe Elektromedizin GmbH
- STERIS PLC
- US Medical Innovations, LLC.
Segment by Type
- Upper GI Tract
- Lower GI Tract
Segment by Application
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gastrointestinal Bleeding Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Bleeding Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Upper GI Tract
1.2.3 Lower GI Tract
1.3 Market by Application
1.3.1 Global Gastrointestinal Bleeding Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Bleeding Treatment Market Perspective (2019-2030)
2.2 Gastrointestinal Bleeding Treatment Growth Trends by Region
2.2.1 Global Gastrointestinal Bleeding Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gastrointestinal Bleeding Treatment Historic Market Size by Region (2019-2024)
2.2.3 Gastrointestinal Bleeding Treatment Forecasted Market Size by Region (2025-2030)
2.3 Gastrointestinal Bleeding Treatment Market Dynamics
2.3.1 Gastrointestinal Bleeding Treatment Industry Trends
2.3.2 Gastrointestinal Bleeding Treatment Market Drivers
2.3.3 Gastrointestinal Bleeding Treatment Market Challenges
2.3.4 Gastrointestinal Bleeding Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Bleeding Treatment Players by Revenue
3.1.1 Global Top Gastrointestinal Bleeding Treatment Players by Revenue (2019-2024)
3.1.2 Global Gastrointestinal Bleeding Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Gastrointestinal Bleeding Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gastrointestinal Bleeding Treatment Revenue
3.4 Global Gastrointestinal Bleeding Treatment Market Concentration Ratio
3.4.1 Global Gastrointestinal Bleeding Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Bleeding Treatment Revenue in 2023
3.5 Gastrointestinal Bleeding Treatment Key Players Head office and Area Served
3.6 Key Players Gastrointestinal Bleeding Treatment Product Solution and Service
3.7 Date of Enter into Gastrointestinal Bleeding Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastrointestinal Bleeding Treatment Breakdown Data by Type
4.1 Global Gastrointestinal Bleeding Treatment Historic Market Size by Type (2019-2024)
4.2 Global Gastrointestinal Bleeding Treatment Forecasted Market Size by Type (2025-2030)
5 Gastrointestinal Bleeding Treatment Breakdown Data by Application
5.1 Global Gastrointestinal Bleeding Treatment Historic Market Size by Application (2019-2024)
5.2 Global Gastrointestinal Bleeding Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gastrointestinal Bleeding Treatment Market Size (2019-2030)
6.2 North America Gastrointestinal Bleeding Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gastrointestinal Bleeding Treatment Market Size by Country (2019-2024)
6.4 North America Gastrointestinal Bleeding Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gastrointestinal Bleeding Treatment Market Size (2019-2030)
7.2 Europe Gastrointestinal Bleeding Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gastrointestinal Bleeding Treatment Market Size by Country (2019-2024)
7.4 Europe Gastrointestinal Bleeding Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Bleeding Treatment Market Size (2019-2030)
8.2 Asia-Pacific Gastrointestinal Bleeding Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gastrointestinal Bleeding Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Gastrointestinal Bleeding Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gastrointestinal Bleeding Treatment Market Size (2019-2030)
9.2 Latin America Gastrointestinal Bleeding Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gastrointestinal Bleeding Treatment Market Size by Country (2019-2024)
9.4 Latin America Gastrointestinal Bleeding Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Bleeding Treatment Market Size (2019-2030)
10.2 Middle East & Africa Gastrointestinal Bleeding Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gastrointestinal Bleeding Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Gastrointestinal Bleeding Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boston Scientific Corporation
11.1.1 Boston Scientific Corporation Company Detail
11.1.2 Boston Scientific Corporation Business Overview
11.1.3 Boston Scientific Corporation Gastrointestinal Bleeding Treatment Introduction
11.1.4 Boston Scientific Corporation Revenue in Gastrointestinal Bleeding Treatment Business (2019-2024)
11.1.5 Boston Scientific Corporation Recent Development
11.2 Olympus Corporation
11.2.1 Olympus Corporation Company Detail
11.2.2 Olympus Corporation Business Overview
11.2.3 Olympus Corporation Gastrointestinal Bleeding Treatment Introduction
11.2.4 Olympus Corporation Revenue in Gastrointestinal Bleeding Treatment Business (2019-2024)
11.2.5 Olympus Corporation Recent Development
11.3 CONMED Corporation
11.3.1 CONMED Corporation Company Detail
11.3.2 CONMED Corporation Business Overview
11.3.3 CONMED Corporation Gastrointestinal Bleeding Treatment Introduction
11.3.4 CONMED Corporation Revenue in Gastrointestinal Bleeding Treatment Business (2019-2024)
11.3.5 CONMED Corporation Recent Development
11.4 Cook Medical
11.4.1 Cook Medical Company Detail
11.4.2 Cook Medical Business Overview
11.4.3 Cook Medical Gastrointestinal Bleeding Treatment Introduction
11.4.4 Cook Medical Revenue in Gastrointestinal Bleeding Treatment Business (2019-2024)
11.4.5 Cook Medical Recent Development
11.5 Ovesco Endoscopy AG
11.5.1 Ovesco Endoscopy AG Company Detail
11.5.2 Ovesco Endoscopy AG Business Overview
11.5.3 Ovesco Endoscopy AG Gastrointestinal Bleeding Treatment Introduction
11.5.4 Ovesco Endoscopy AG Revenue in Gastrointestinal Bleeding Treatment Business (2019-2024)
11.5.5 Ovesco Endoscopy AG Recent Development
11.6 Erbe Elektromedizin GmbH
11.6.1 Erbe Elektromedizin GmbH Company Detail
11.6.2 Erbe Elektromedizin GmbH Business Overview
11.6.3 Erbe Elektromedizin GmbH Gastrointestinal Bleeding Treatment Introduction
11.6.4 Erbe Elektromedizin GmbH Revenue in Gastrointestinal Bleeding Treatment Business (2019-2024)
11.6.5 Erbe Elektromedizin GmbH Recent Development
11.7 STERIS PLC
11.7.1 STERIS PLC Company Detail
11.7.2 STERIS PLC Business Overview
11.7.3 STERIS PLC Gastrointestinal Bleeding Treatment Introduction
11.7.4 STERIS PLC Revenue in Gastrointestinal Bleeding Treatment Business (2019-2024)
11.7.5 STERIS PLC Recent Development
11.8 US Medical Innovations, LLC.
11.8.1 US Medical Innovations, LLC. Company Detail
11.8.2 US Medical Innovations, LLC. Business Overview
11.8.3 US Medical Innovations, LLC. Gastrointestinal Bleeding Treatment Introduction
11.8.4 US Medical Innovations, LLC. Revenue in Gastrointestinal Bleeding Treatment Business (2019-2024)
11.8.5 US Medical Innovations, LLC. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
